<?php /* Template Name: References */ ?>

<?php get_header('references'); ?>
<?php get_header(); ?>

<div class="bg-0">
	<div class="container">
    <div class="col-sm-8 col-sm-offset-2">
        <br><br>
    	<h1 class="gradient">References</h1>
    	<br>

    	<div class="panel panel-default">
		  <div class="panel-body"><p>* Recommended Duration of Use: Use for up to one week. Please consult a healthcare practitioner if symptoms of digestive upset (e.g. diarrhea) worsen or persist beyond three days.</p></div>
		</div>
		
    </div>
    </div>
</div>

<div class="bg-1">
   <div class="container">
    <div class="col-sm-8 col-sm-offset-2">
		<ol id="numbered-list">
			<li>Swidsinski, A., Loening-Baucke, V., Verstraelen, H., Osowska, S., &amp; Doerffel, Y. (2008). Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. <em>Gastroenterology</em>, <em>135</em>(2), 568-579.</li>

		 	<li>Buts, J.P., Bernasconi, P., Van Craynest, M.P., Maldague, P., &amp; De Meyer, R. (1986). Response of human and rat small intestinal mucosa to oral administration of <em>Saccharomyces boulardii</em>. <em>Pediatric Research,</em> <em>20</em>, 192-196.</li>

		 	<li>Klein, S.M., Elmer, G.W., McFarland, L.V., Surawicz, C.M., &amp; Levy, R.H. (1993). Recovery and elimination of the biotherapeutic agent, <em>Saccharomyces boulardii</em>, in healthy human volunteers. <em>Pharmaceutical Research</em>, <em>10</em>, 1615-1619.</li>

		 	<li>Szajewska, H. &amp; Kołodziej, M. (2015). Systematic review with meta‐analysis: <em>Saccharomyces boulardii</em> in the prevention of antibiotic‐associated diarrhoea. <em>Alimentary Pharmacology &amp; Therapeutics, 42</em>(7), 793-801.</li>
		 	
		 	<li>Kotowska, M., Albrecht, P., &amp; Szajewska, H. (2005). <em>Saccharomyces boulardii</em> in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial. <em>Aliment Pharmacology &amp; Therapeutics, 21</em>, 583-590.</li>
		 	
		 	<li>Villarruel, G., Rubio, D.M., Lopez, F., Cintioni, J., Gurevech, R., et al. (2007). <em>Saccharomyces boulardii</em> in acute childhood diarrhoea: a randomized, placebo‐controlled study. <em>Acta Paediatrica, 96</em>(4), 538-541.</li>
		 	
		 	<li>Blehaut, H., Massot, J., Elmer, G.W., &amp; Levy, R.H. (1989). Disposition kinetics of <em>Saccharomyces boulardii</em> in man and rat. <em>Biopharmaceutics &amp; Drug Disposition, 10</em>(4), 353-364.</li>
		 	
		 	<li>Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food (2002) Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada: FAO/WHO.</li>
		 	
		 	<li>IMS Data 2017.</li>
		 	
		 	<li>Health Canada. (2015, May) Probiotics (Monograph). Retrieved from <a href="http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng">www.hc-sc.gc.ca</a></li>
		 	
		 	<li>Dinleyici, E.C., Eren, M., Ozen, M., Yargic, Z.A., &amp; Vandenplas, Y. (2012). Effectiveness and safety of <em>Saccharomyces boulardii</em> for acute infectious diarrhea. <em>Expert Opinion on Biological Therapy, 12</em>(4), 395-410.</li>
		 	<li>Neut, C., Mahieux, S., & Dubreuil, L. J. (2017). Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?. Medecine et maladies infectieuses, 47(7), 477-483.</li>
		 	<li>Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-Galvez, J., Vanga, R. R., et al. (2017). Prospective randomized controlled study on the effects of <em>Saccharomyces boulardii</em> CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes, 1, 17-32.</li>
		</ol>
        <br>
    </div>
    </div>
</div>
        
<?php get_footer(); ?>